The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Adult Minimal-Change Disease: Clinical Characteristics, Treatment, and Outcomes
Abstract
Minimal-change disease (MCD) counts for 10 to 15% of cases of primary nephrotic syndrome in adults. Few series have examined this disease in adults. A retrospective review was performed of 95 adults who had MCD and were seen at a single referral center. Examined were presenting features, response to daily versus alternate-day steroids, response to second-line agents, relapse patterns, complications of the disease and therapy, presence of acute renal failure (ARF), and outcome data. Sixty-five patients received daily and 23 received alternate-day steroids initially. There were no differences in remissions, time to remission, relapse rate, or time to relapse between daily- and alternate-day-treated patients. More than one quarter of patients were steroid resistant. At least one relapse occurred in 73% of patients; 28% were frequently relapsing. A significant proportion of frequently relapsing patients became steroid dependent. Second-line agents were used for steroid dependence, steroid resistance, or frequent relapses. No single agent proved superior. There were more remissions with second-line agents in steroid-dependent patients compared with steroid-resistant patients, and remissions were more likely to be complete in steroid-dependent patients. ARF occurred in 24 patients; they tended to be older and hypertensive with lower serum albumin and more proteinuria than those without ARF. At follow up, patients with an episode of ARF had higher serum creatinine than those without ARF. Four patients progressed to ESRD. These patients were less likely to have responded to steroids and more likely to have FSGS on repeat renal biopsy. In this referral MCD population, response to daily and alternate-day steroids is similar. Second-line agents give greater response in patients who are steroid dependent. ARF occurs in a significant number of adult MCD patients and may leave residual renal dysfunction. Few patients progress to ESRD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nephrotic syndrome in childhood
Eddy, A. A., & Symons, J. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14184-0 · Cited by 954
A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome
Ponticelli, C., Rizzoni, G., Edefonti, A., Altieri, P., Rivolta, E., Rinaldi, S., Ghio, L., Lusvarghi, E., Gusmano, R., Locatelli, F., et al. (1993) · Kidney International · doi:10.1038/ki.1993.194 · Cited by 288
WANG, Y., RANGAN, G. K., TAY, Y.-C., WANG, Y., & HARRIS, D. C. H. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1061204 · Cited by 208
Albumin induces endoplasmic reticulum stress and apoptosis in renal proximal tubular cells
Ohse, T., Inagi, R., Tanaka, T., Ota, T., Miyata, T., Kojima, I., Ingelfinger, J. R., Ogawa, S., Fujita, T., & Nangaku, M. (2006) · Kidney International · doi:10.1038/sj.ki.5001704 · Cited by 200
Cyclosporine A induced remission of relapsing nephrotic syndrome in children
Tejani, A., Butt, K., Trachtman, H., Suthanthiran, M., Rosenthal, C. J., & Khawar, M. R. (1988) · Kidney International · doi:10.1038/ki.1988.59 · Cited by 168
Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome
Nakayama, M., Katafuchi, R., Yanase, T., et al. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.31400 · Cited by 156
Cellular responses to protein overload: key event in renal disease progression
Zoja, C., Benigni, A., & Remuzzi, G. (2003) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200401000-00005 · Cited by 148
Renal failure in minimal change nephrotic syndrome
Lowenstein, J., Schacht, R. G., & Baldwin, D. S. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90754-3 · Cited by 141
The nephrotic syndrome in adults aged over 60: etiology, evolution and treatment of 76 cases.
Zech, P. Y., Colon, S., Pointet, P., Deteix, P., Labeeuw, M., & Leitienne, P. (1982) · PubMed · Cited by 133
Proteinuria induces tubular cell turnover: A potential mechanism for tubular atrophy
Thomas, M. E., Brunskill, N. J., Harris, K. P. G., Bailey, E., Pringle, J. H., Furness, P. N., & Walls, J. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.055003890.x · Cited by 128
Cited by
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Rovin, B. H., Adler, S. G., Barratt, J., Bridoux, F., Burdge, K. A., Chan, T. M., Cook, H. T., Fervenza, F. C., Gibson, K. L., Glassock, R. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.05.021 · Cited by 2,518
Kopp, J. B., Anders, H.-J., Susztak, K., Podestà, M. A., Remuzzi, G., Hildebrandt, F., & Romagnani, P. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0196-7 · Cited by 562
Vivarelli, M., Massella, L., Ruggiero, B., & Emma, F. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05000516 · Cited by 557
Rituximab in Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome
Ruggenenti, P., Ruggiero, B., Cravedi, P., Vivarelli, M., Massella, L., Marasà, M., Chianca, A., Rubis, N., Ene-Iordache, B., Rudnicki, M., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013030251 · Cited by 267
Renal toxicity of therapeutic drugs
John, R., & Herzenberg, A. M. (2009) · Journal of Clinical Pathology · doi:10.1136/jcp.2008.058271 · Cited by 93
Metadata
- Authors
- Waldman, M., Crew, R. J., Valeri, A., Busch, J., Stokes, B., Markowitz, G., D'Agati, V., & Appel, G.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2007-05
- Volume
- 2
- Issue
- 3
- Pages
- 445-453
- ISSN
- 1555-9041 (ISSN-L)
- OpenAlex
- W2052862354
- Cited by
- 420
- References
- 14
- FWCI
- 4.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adult Minimal-Change Disease: Clinical Characteristics, Treatment, and Outcomes. https://app.cochat.ai/papers/10.2215/cjn.03531006
- The paper
- Waldman, M., Crew, R. J., Valeri, A., Busch, J., Stokes, B., Markowitz, G., D'Agati, V., & Appel, G. (2007). Adult Minimal-Change Disease: Clinical Characteristics, Treatment, and Outcomes. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.03531006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.